New Rx instructions tighten use of controversial Alzheimer’s disease drug
Jul 08, 2021
Major changes to prescribing instructions are rare, especially so soon after approval; it change could curb the drug’s use.
Pricey Alzheimer drug drives spike in Medicare B premium: Officials
Nov 15, 2021
New premium will be $170.10 a month, and the $21.60 boost is the biggest increase ever in dollar amount, but not in percentage terms
Financial incentives might tempt facilities to admit infected residents: LA Times
By
Amy Novotney
May 05, 2020
In an industry devastated by the coronavirus, some patient advocates and industry experts fear nursing home operators may seek to take advantage of the premium pay offered for admitting COVID-19-positive...
More news for Thursday, Jan. 26
Jan 25, 2017
Gene-blocking therapy reverses Alzheimer’s-like symptoms … New bill would increase temp worker protections … Projected $10 trillion federal debt growth over next decade may affect plans...
Medicare claims data can aid development decisions: NIC MAP Vision
By
Kathleen Steele Gaivin
Oct 05, 2021
Operators trying to determine which markets are under- or over-served can use Medicare data to make better development decisions, according to Arick Morton, CEO of NIC MAP Vision.
Long-term care resident Medicare beneficiaries spend $22,384 out of pocket for healthcare annually: study
By
Lois A. Bowers
Nov 06, 2019
Residents of long-term care facilities who have traditional Medicare coverage spent an average of $22,384 out of pocket for healthcare in 2016, the latest data available, according to a new analysis of...
Biogen cuts price of controversial Aduhelm in half
Dec 21, 2021
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.
Medicare mulls coverage for controversial drug for Alzheimer’s disease
Jul 13, 2021
CMS says a final decision on coverage is not likely until next spring.
Geriatrician calls for move to value-based care model for home care
By
Diane Eastabrook
Apr 19, 2021
Medicare and private insurers must quickly transition to a value-based-care payment model to meet the needs of an aging population, the head of Geriatric Medicine at the University of Virginia (UVA) told...
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.